Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ERN1 | O75460 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CCR2 | P41597 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 3/20 | 0.31 |
| ▸ | CASP7 | P55210 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.30 |
| ▸ | PNP | P00491 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31050378 | 0.85 | ALDH1A1 (0.33) | ALDH1A1ERN1MEN1KMT2ACCR2 | |
| SCHEMBL16960520 | 0.83 | ALDH1A1 (0.36) | ALDH1A1ERN1CCR2HPGDTSHR | |
| SCHEMBL31050324 | 0.83 | ERN1 (0.52) | ALDH1A1ERN1CA12CA9CCR2 | |
| SCHEMBL1017248 | 0.83 | ERN1 (0.52) | ALDH1A1ERN1CA12CA9CCR2 | |
| SCHEMBL16952858 | 0.83 | ERN1 (0.38) | ALDH1A1ERN1MEN1KMT2ACA12 | |
| SCHEMBL3107273 | 0.77 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2ACCR2TSHR | |
| SCHEMBL1019839 | 0.76 | GAA (0.39) | ALDH1A1MEN1KMT2AHPGDTSHR | |
| SCHEMBL1261937 | 0.76 | GAA (0.39) | ALDH1A1MEN1KMT2AHPGDTSHR | |
| SCHEMBL2645981 | 0.75 | ALOX15 (0.42) | ALDH1A1MEN1KMT2ACCR2HPGD | |
| SCHEMBL2781542 | 0.73 | ALDH1A1 (0.42) | ALDH1A1CCR2HPGDTSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283660-B2 | Small molecule semiconductor | XEROX CORPORATION (US) | 2012-10-09 | — | — | US | disclosed |
| US-8283660-B2 | Small molecule semiconductor | XEROX CORPORATION (US) | 2012-10-09 | — | — | US | disclosed |
| US-20120161109-A1 | SMALL MOLECULE SEMICONDUCTOR | XEROX CORPORATION (US) | 2012-06-28 | — | — | US | disclosed |
| US-20120161109-A1 | SMALL MOLECULE SEMICONDUCTOR | XEROX CORPORATION (US) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120161109-A1 | SMALL MOLECULE SEMICONDUCTOR | SLC43A1, TST, SLC7A5 | ALDH1A1 1129/4885ERN1 3101/4885MEN1 579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.